Management of localized prostate cancer: the pendulum swings (back to the middle) by Winston Vuong, Oliver Sartor, Sumanta K Pal

Get full text

Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020 by Neal S. Chawla, Jasnoor Malhotra, Sumanta K. Pal

Get full text

Radium-223 in metastatic castration resistant prostate cancer by Winston Vuong, Oliver Sartor, Sumanta K Pal

Get full text

Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era. by Sumanta K Pal, Rebecca A Nelson, Nicholas Vogelzang

Get full text

The role of peroxisome proliferator-activated receptor gamma in prostate cancer by Catherine Elix, Sumanta K Pal, Jeremy O Jones

Get full text

CYP17 inhibitors in prostate cancer: latest evidence and clinical potential by Anitha B. Alex, Sumanta K. Pal, Neeraj Agarwal

Get full text

Defining the Mycobiome in Bladder Cancer by Benjamin D. Mercier, Daniela V. Castro, Sumanta K. Pal

Get full text

Cytoreductive Nephrectomy in 2021: Obsolete by Luis Meza, Neal S. Chawla, Gianluca Giannarini, Sumanta K. Pal

Get full text

Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma by Luis Meza, Ameish Govindarajan, Matthew Feng, Sumanta K. Pal

Get full text

Utilization of systemic therapy for treatment of advanced urothelial carcinoma: Lessons from real world experience by Umang Swami, Petros Grivas, Sumanta K. Pal, Neeraj Agarwal

Get full text

Tivozanib in renal cell carcinoma: a new approach to previously treated disease by Nicholas J. Salgia, Zeynep B. Zengin, Sumanta K. Pal

Get full text

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells by Ben T. Copeland, Juan Du, Sumanta K. Pal, Jeremy O. Jones

Get full text

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma by Jacob J. Adashek, Meghan Salgia, Nazli Dizman, Jonathan Kessler, Sumanta K. Pal

Get full text

Metastasis in renal cell carcinoma: Biology and implications for therapy by Jun Gong, Manuel Caitano Maia, Nazli Dizman, Ameish Govindarajan, Sumanta K. Pal

Get full text

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials by Patrick L. Sweeney, Albert Jang, Shams K. Halat, Sumanta K. Pal, Pedro C. Barata

Get full text

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond by Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang

Get full text

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors by Chiara Casadei, Nazli Dizman, Giuseppe Schepisi, Maria Concetta Cursano, Umberto Basso, Daniele Santini, Sumanta K. Pal, Ugo De Giorgi

Get full text

Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer. by Wang Zhang, Sumanta K Pal, Xueli Liu, Chunmei Yang, Sachin Allahabadi, Shaira Bhanji, Robert A Figlin, Hua Yu, Karen L Reckamp

Get full text

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium by Sumanta K. Pal, Ben Yi Tew, Minyoung Lim, Brittany Stankavich, Miaoling He, Miles Pufall, Weidong Hu, Yuan Chen, Jeremy O. Jones

Get full text

CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer. by Sumanta K Pal, Nora Ruel, Sergio Villegas, Mark Chang, Kara DeWalt, Timothy G Wilson, Nicholas J Vogelzang, Bertram E Yuh

Get full text